The patient of young age with breast cancer often choose conduct bilateral mastectomy

Women of young age with operable breast cancer (BC) are increasingly choosing conducting a bilateral mastectomy with immediate reconstruction and not conserving surgery regardless of response to neoadjuvant chemotherapy. These are the results of the research presented at the Symposium on breast Continue reading “The patient of young age with breast cancer often choose conduct bilateral mastectomy”

For the first time in 30 years can be changed first-line therapy in Hodgkin’s lymphoma

Anticancer drug brentuximab vicodin (brentuximab vedotin), approved for the treatment of patients with relapsed and refractory Hodgkin’s lymphoma, may be included in the initial therapy of patients with advanced Hodgkin’s lymphoma. The results of the study ECHELON-1 was presented at the annual Continue reading “For the first time in 30 years can be changed first-line therapy in Hodgkin’s lymphoma”